Mitarbeiter: NN (None)Rechtsform: SCA (commandite par actions)Größe: PMEGründungsdatum: 2020-12-17 (5 Jahre)Status: AktivBranche: Conseil pour les affaires et autres conseils de gestionStandort: CHARENTON-LE-PONT (94220), Val-de-Marne
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
JSK MEDICAL : revenue, balance sheet and financial ratios
JSK MEDICAL is a French company
founded 5 years ago,
specialized in the sector Conseil pour les affaires et autres conseils de gestion.
Based in CHARENTON-LE-PONT (94220),
this company of category PME
shows in 2024 a net income positive of 305 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Historique financier - JSK MEDICAL (SIREN 892532722)
Kennzahl
2024
2023
2022
Umsatz
N/C
N/C
N/C
Nettoergebnis
304 986 €
298 598 €
434 767 €
EBITDA
N/C
N/C
N/C
Nettomarge
N/C
N/C
N/C
Umsatz und Gewinn- und Verlustrechnung
In 2024, JSK MEDICAL generates positive net income of 305 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2022-2024: 435 k€ -> 305 k€.
Nettoergebnis (2024)
?
Nettoergebnis
Definition
Bénéfice ou perte après toutes les charges, y compris impôts et éléments exceptionnels.
Le compte de résultat détaillé n'est pas disponible pour cette entreprise (liasse simplifiée ou données confidentielles).
Évolution graphique
Anzeigen :
Visualisierung erstellt mit numbers.finance Sources : INPI & BCE - Anpassungen : Ministère de l'Économie
Aktiva
Chargement des données...
Poste
Brutto
Abschr.
Netto
%
Entwicklung
Données de bilan actif non disponibles pour cette entreprise
Passiva
Chargement des données...
Poste
Jahr
%
Entwicklung
Données de bilan passif non disponibles pour cette entreprise
Solvenz- und Verschuldungskennzahlen
The debt ratio (= Financial debt / Equity x 100) stands at 1%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 76%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Verschuldungsgrad (2024)
?
Verschuldungsgrad
Definition
Misst das Verhältnis von Schulden zu Eigenkapital.
Formel
(Finanzschulden / Eigenkapital) x 100
Interpretation
< 50% : Faible 50-100% : Moderat > 100% : Hoch
1.408%
Finanzielle Autonomie (2024)
?
Finanzielle Autonomie
Definition
Anteil des Eigenkapitals an der Gesamtfinanzierung.
Visualisierung erstellt mit numbers.finance Sources : INPI & BCE - Anpassungen : Ministère de l'Économie
Kennzahl
2022
2023
2024
Verschuldungsgrad
1.934
1.715
1.408
Finanzielle Autonomie
59.982
67.059
76.055
Rückzahlungsfähigkeit
None
None
None
Cashflow / Umsatz
None%
None%
None%
Positionnement sectoriel
Debt ratio
1.412024
2022
2023
2024
Q1: 0.0
Méd: 3.98
Q3: 41.81
Good
In 2024, the debt ratio of JSK MEDICAL (1.41) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
76.06%2024
2022
2023
2024
Q1: 4.2%
Méd: 38.87%
Q3: 76.44%
Good+11 pts über 3 Jahre
In 2024, the financial autonomy of JSK MEDICAL (76.1%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquiditätskennzahlen
The liquidity ratio (= Current assets / Current liabilities) stands at 391.83. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquiditätsquote (2024)
?
Liquiditätsquote
Definition
Fähigkeit, kurzfristige Schulden mit dem Umlaufvermögen zu decken.
Formel
Umlaufvermögen / Kurzfristige Verbindlichkeiten
Interpretation
> 1.5 : Sehr gut 1-1.5 : Angemessen < 1 : Risque de liquidité
391.831
Entwicklung der Liquiditätskennzahlen JSK MEDICAL
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Kennzahl
2022
2023
2024
Liquiditätsquote
237.862
282.521
391.831
Zinsdeckung
None
None
None
Positionnement sectoriel
Liquidity ratio
391.832024
2022
2023
2024
Q1: 138.87
Méd: 313.12
Q3: 966.61
Good+11 pts über 3 Jahre
In 2024, the liquidity ratio of JSK MEDICAL (391.83) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positionnement de JSK MEDICAL dans son secteur
Vergleich mit der Branche Conseil pour les affaires et autres conseils de gestion
Bewertungsschätzung
Based on 69 transactions of similar company sales
in 2024,
the value of JSK MEDICAL is estimated at
2 112 182 €
(range 797 514€ - 5 287 391€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate. Medium reliability: estimate to be confirmed with in-depth analysis.
Estimated enterprise value2024
69 tx
797k€2112k€5287k€
2 112 182 €Range: 797 514€ - 5 287 391€
NAF 5 année 2024
Valuation method used
Net Income Multiple
304 986 €
×
6.9x
=2 112 183 €
Range: 797 514€ - 5 287 392€
Only this financial indicator is available for this company.
Bewertungsentwicklung
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 69 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Conseil pour les affaires et autres conseils de gestion)
Compare JSK MEDICAL with other companies in the same sector:
The revenue of JSK MEDICAL is not publicly disclosed (confidential accounts filed with INPI).
Is JSK MEDICAL profitable?
Yes, JSK MEDICAL generated a net profit of 305 k€ in 2024.
Where is the headquarters of JSK MEDICAL ?
The headquarters of JSK MEDICAL is located in CHARENTON-LE-PONT (94220), in the department Val-de-Marne.
Where to find the tax return of JSK MEDICAL ?
The tax return of JSK MEDICAL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does JSK MEDICAL operate?
JSK MEDICAL operates in the sector Conseil pour les affaires et autres conseils de gestion (NAF code 70.22Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Drehen Sie Ihr Telefon ins Querformat, um das Diagramm anzuzeigen